“…To measure exNMDAR current, a shift in the whole-cell current in response to a treatment of 50 μM (2R)-amino-5-phosphonovaleric acid (APV), the NMDAR blocker, was quantified under voltage-clamping at +40mV in the presence of other inhibitors (20 μM CNQX for AMPAR, 10 μM Bicuculline for GABA A R, 10 μM CGP 55845 for GABA B R, 10 μM Strychnine for GlyR) (Figure 1A). To inhibit astrocytic Ca 2+ signaling, BAPTA, a Ca 2+ chelator, and Alexa Fluor 488, a fluorescent indicator, were loaded into astrocytes through a patch pipette (Figures 1B and S1A), as previously described (Kwak et al, 2020; Serrano et al, 2006; Shigetomi et al, 2008). We observed that exNMDAR current was significantly reduced when astrocytes were loaded with BAPTA (+BAPTA), compared to without BAPTA (-BAPTA) condition (Figures 1C and 1D).…”